NASDAQ:ILMN
Illumina Stock News
$124.68
+1.63 (+1.32%)
At Close: May 01, 2024
Illumina (ILMN), Helix Partner to Develop Tracking Setup in U.S.
11:17am, Monday, 11'th Jan 2021
Illumina (ILMN) collaborates with Helix with support from the CDC to set up an enhanced surveillance infrastructure to track the emergence and prevalence of B.1.1.7.
SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (Nasdaq: ILMN) and Helix today announced a collaboration to augment national surveillance infrastructure in the US to track the emergence and prevalence of n
Active Traders Look to Biotech for 2021
09:10am, Tuesday, 05'th Jan 2021
Due to lucrative risk/reward setups and heightened fundamental demand, many active traders will be watching biotech stocks.
Here's Why You Should Hold on to Illumina (ILMN) Stock for Now
10:32am, Thursday, 31'st Dec 2020
Investors continue to be optimistic about Illumina (ILMN), backed by its focus on partnerships and worldwide expansion to drive growth.
Illumina to Webcast Upcoming Investor Conference Presentations
07:00am, Tuesday, 22'nd Dec 2020
SAN DIEGO--(BUSINESS WIRE)---- $ILMN #ILMN--Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference and invited investors to participate
7 Healthcare Stocks to Buy With the Sector Under Scrutiny
10:53am, Monday, 21'st Dec 2020
True, there are political risks in the industry. But there are also lots of growth opportunities for investors in healthcare stocks.
Illumina, Inc. (ILMN) Presents at Piper Sandler Healthcare Broker Conference Call - (Transcript)
07:06pm, Thursday, 03'rd Dec 2020
Illumina, Inc. (ILMN) Presents at Piper Sandler Healthcare Broker Conference Call - (Transcript)
PierianDx Announces Expanded Partnership with Illumina to Support Cancer Genomic Reporting in Global Markets
11:00am, Tuesday, 01'st Dec 2020
ST. LOUIS--(BUSINESS WIRE)--Additional Illumina assays to be combined with the PierianDx platform to reduce time, cost, and complexity of genomic reporting
Illumina Looks Like Great Value Compared To Intuitive Surgical Stock
10:00am, Friday, 20'th Nov 2020
Illumina, best known for its genetic variation and biological function systems, trades at about 12x trailing Revenues, compared to over 19x for Intuitive Surgical, which manufactures robotic surgical
Liquid Biopsy Cancer Testing Is The Next Big Investment Opportunity
09:25am, Tuesday, 17'th Nov 2020
Multiple companies are working on next-gen blood biopsies tech to detect cancer. The potential market size is big according to most estimates and analysts.
Wild Ride For Illumina Stock Shows Promise, Challenge Of Multi-Cancer Blood Tests
08:30am, Friday, 13'th Nov 2020
Liquid biopsy technology offers promise of the medical Holy Grail, early detection of multiple cancers. Illumina, Exact Sciences deals heating up a game-changing field in cancer treatment.
Realize the Full Potential of the NextSeq 2000 with the Power of the P3 Reagent Kit
08:00pm, Thursday, 12'th Nov 2020
SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ: ILMN) is further extending the reach of the NextSeq™ 2000 Sequencing System with the commercial availability of the P3 high-output flow cell. The
Why Illumina's Q3 Results Were Better Than They Might Seem
06:05am, Friday, 30'th Oct 2020
The genomic-sequencing leader is recovering more quickly from the COVID-19 pandemic than it anticipated.
Illumina Inc. (ILMN) CEO Francis deSouza on Q3 2020 Results - Earnings Call Transcript
10:48pm, Thursday, 29'th Oct 2020
Illumina Inc. (ILMN) CEO Francis deSouza on Q3 2020 Results - Earnings Call Transcript
Illumina: Q3 Earnings Insights
05:11pm, Thursday, 29'th Oct 2020
Shares of Illumina (NASDAQ:ILMN) were flat in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share were down 47.15% over the past year to $1.02, which beat
